Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial

@inproceedings{Robinson2010EnoxaparinED,
  title={Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial},
  author={S{\^i}an Robinson and Aleksander Zincuk and Thomas Str\om and Torben Bjerregaard Larsen and Bjarne Rasmussen and Palle Toft},
  booktitle={Critical care},
  year={2010}
}
INTRODUCTION Intensive care unit (ICU) patients are predisposed to thromboembolism. Routine prophylactic anticoagulation is widely recommended. Low-molecular-weight heparins, such as enoxaparin, are increasingly used because of predictable pharmacokinetics. This study aims to determine the subcutaneous (SC) dose of enoxaparin that would give the best anti-factor Xa levels in ICU patients. METHODS The 72 patients admitted to a mixed ICU at Odense University Hospital (OUH) in Denmark were… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

The pharmacokinetics of enoxaparin do not correlate with its pharmacodynamic effect in patients receiving dialysis therapies

  • DF Brophy, ME JrCarr, EJ Martin, J Venitz, TW Gehr
  • J Clin Pharmacol
  • 2006
1 Excerpt

Similar Papers

Loading similar papers…